Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Felsing

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Medicinal Chemistry|November 17, 2020
Discovery of Potent and Brain-Penetrant GPR52 Agonist that Suppresses Psychostimulant BehaviorPingyuan Wang, Daniel E Felsing, Haiying Chen, et al.
Bioorganic & Medicinal Chemistry|December 29, 2019
Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT<sub>1A</sub> and 5-HT<sub>7</sub> G protein-coupled receptor affinity, 3D-QSAR and molecular modelingCharles K Perry, Austen B Casey, Daniel E Felsing, et al.
Scientific Reports|November 15, 2019
Serotonin 5-HT<sub>2C</sub> Receptor Cys23Ser Single Nucleotide Polymorphism Associates with Receptor Function and Localization In VitroMichelle A Land, Holly L Chapman, Brionna D Davis-Reyes, et al.
Pharmacology Research & Perspectives|August 29, 2018
Small-Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal ModelsCatherine M Sampson, James M Kasper, Daniel E Felsing, et al.
Neuroscience|April 3, 2021
Maternal Opioid Exposure Culminates in Perturbed Murine Neurodevelopment and Hyperactive Phenotype in AdolescenceCaitlin R Schlagal, Tiffany J Dunn, Pei Xu, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Medicinal Chemistry|November 17, 2020
Discovery of Potent and Brain-Penetrant GPR52 Agonist that Suppresses Psychostimulant BehaviorPingyuan Wang, Daniel E Felsing, Haiying Chen, et al.
Bioorganic & Medicinal Chemistry|December 29, 2019
Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT<sub>1A</sub> and 5-HT<sub>7</sub> G protein-coupled receptor affinity, 3D-QSAR and molecular modelingCharles K Perry, Austen B Casey, Daniel E Felsing, et al.
Scientific Reports|November 15, 2019
Serotonin 5-HT<sub>2C</sub> Receptor Cys23Ser Single Nucleotide Polymorphism Associates with Receptor Function and Localization In VitroMichelle A Land, Holly L Chapman, Brionna D Davis-Reyes, et al.
Pharmacology Research & Perspectives|August 29, 2018
Small-Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal ModelsCatherine M Sampson, James M Kasper, Daniel E Felsing, et al.
Neuroscience|April 3, 2021
Maternal Opioid Exposure Culminates in Perturbed Murine Neurodevelopment and Hyperactive Phenotype in AdolescenceCaitlin R Schlagal, Tiffany J Dunn, Pei Xu, et al.
Pageof 2